Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07774325 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study in Healthy Men to Find Out How Blocking Certain Transport Proteins Affects the Amount of BI 3000202 in the Blood

StatusRecruiting
PhasePhase 1
Started2026-09-01
View on ClinicalTrials.gov ↗
The main objective of this trial is to investigate the effects of multiple doses of Itraconazole and multiple doses of Ciclosporin on the pharmacokinetics of BI 3000202 in plasma following a single oral dose in healthy male trial participants.

Amendment history 1 change detected by DataLookout

2026-09-10
notable
Recruitment opened
Trial Details
NCT Number NCT07774325
Lead Sponsor Boehringer Ingelheim
Conditions Healthy
Enrollment 16 participants
Start Date 2026-09-01
Primary Completion 2026-10-06 (estimated)
Study Completion 2026-10-26 (estimated)
Updated on ClinicalTrials.gov 2026-09-09